232
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Adderall XR: long acting stimulant for single daily dosing

&
Pages 927-934 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mary B. Haffey, Mary Buckwalter, Pinggao Zhang, Robert Homolka, Patrick Martin, Kenneth C. Lasseter & James C. Ermer. (2009) Effects of Omeprazole on the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Extended-Release Mixed Amphetamine Salts in Adults. Postgraduate Medicine 121:5, pages 11-19.
Read now

Articles from other publishers (6)

Valentina Gumenyuk, Oleg Korzyukov, Natalie Tapaskar, Michael Wagner, Charles R Larson & Michael J. Hammer. (2022) Deficiency in Re-Orienting of Attention in Adults with Attention-Deficit Hyperactivity Disorder. Clinical EEG and Neuroscience 54:2, pages 141-150.
Crossref
Nadia R.P.W. Hutten, Laura Steenbergen, Lorenza S. Colzato, Bernhard Hommel, Eef L. Theunissen, Johannes G. Ramaekers & Kim P.C. Kuypers. (2019) Cocaine enhances figural, but impairs verbal ‘flexible’ divergent thinking. European Neuropsychopharmacology 29:7, pages 813-824.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 145 153 .
Oleg Korzyukov, Natalie Tapaskar, Mark E. Pflieger, Roozbeh Behroozmand, Anjli Lodhavia, Sona Patel, Donald A. Robin & Charles Larson. (2015) Event related potentials study of aberrations in voice control mechanisms in adults with attention deficit hyperactivity disorder. Clinical Neurophysiology 126:6, pages 1159-1170.
Crossref
John D. McCorvy, Aubrie A. Harland, Rebecca Maglathlin & David E. Nichols. (2011) A 5-HT2C receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference. Neuroscience Letters 505:1, pages 10-13.
Crossref
James C. Ermer, Ben A. Adeyi & Michael L. Pucci. (2010) Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder. CNS Drugs 24:12, pages 1009-1025.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.